Logo image of ARBE

ARBE ROBOTICS LTD (ARBE) Stock Fundamental Analysis

USA - NASDAQ:ARBE - IL0011796625 - Common Stock

2.64 USD
+0.28 (+11.86%)
Last: 10/14/2025, 8:00:00 PM
2.61 USD
-0.03 (-1.14%)
After Hours: 10/14/2025, 7:59:04 PM
Fundamental Rating

2

Overall ARBE gets a fundamental rating of 2 out of 10. We evaluated ARBE against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of ARBE have multiple concerns. ARBE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARBE had negative earnings in the past year.
In the past year ARBE has reported a negative cash flow from operations.
ARBE had negative earnings in each of the past 5 years.
ARBE had a negative operating cash flow in each of the past 5 years.
ARBE Yearly Net Income VS EBIT VS OCF VS FCFARBE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

ARBE has a Return On Assets of -64.28%. This is amonst the worse of the industry: ARBE underperforms 87.90% of its industry peers.
ARBE has a Return On Equity of -84.07%. This is amonst the worse of the industry: ARBE underperforms 80.65% of its industry peers.
Industry RankSector Rank
ROA -64.28%
ROE -84.07%
ROIC N/A
ROA(3y)-77.96%
ROA(5y)-128.86%
ROE(3y)-135.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARBE Yearly ROA, ROE, ROICARBE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

ARBE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARBE Yearly Profit, Operating, Gross MarginsARBE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

ARBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARBE has been increased compared to 1 year ago.
The number of shares outstanding for ARBE has been increased compared to 5 years ago.
The debt/assets ratio for ARBE is higher compared to a year ago.
ARBE Yearly Shares OutstandingARBE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARBE Yearly Total Debt VS Total AssetsARBE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that ARBE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.67, ARBE is doing worse than 72.58% of the companies in the same industry.
ARBE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
ARBE's Debt to Equity ratio of 0.16 is in line compared to the rest of the industry. ARBE outperforms 49.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACCN/A
WACC8.87%
ARBE Yearly LT Debt VS Equity VS FCFARBE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

ARBE has a Current Ratio of 2.34. This indicates that ARBE is financially healthy and has no problem in meeting its short term obligations.
ARBE has a Current ratio of 2.34. This is comparable to the rest of the industry: ARBE outperforms 50.81% of its industry peers.
ARBE has a Quick Ratio of 2.34. This indicates that ARBE is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.34, ARBE is doing good in the industry, outperforming 66.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.34
ARBE Yearly Current Assets VS Current LiabilitesARBE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

ARBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.50%, which is quite good.
The Revenue for ARBE has decreased by -64.48% in the past year. This is quite bad
The Revenue for ARBE have been decreasing by -30.11% on average. This is quite bad
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)-64.48%
Revenue growth 3Y-30.11%
Revenue growth 5YN/A
Sales Q2Q%-33.01%

3.2 Future

Based on estimates for the next years, ARBE will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.62% on average per year.
The Revenue is expected to grow by 152.15% on average over the next years. This is a very strong growth
EPS Next Y33.31%
EPS Next 2Y19.47%
EPS Next 3Y15.21%
EPS Next 5Y17.62%
Revenue Next Year106.7%
Revenue Next 2Y169.17%
Revenue Next 3Y190.21%
Revenue Next 5Y152.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARBE Yearly Revenue VS EstimatesARBE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ARBE Yearly EPS VS EstimatesARBE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ARBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARBE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARBE Price Earnings VS Forward Price EarningsARBE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARBE Per share dataARBE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as ARBE's earnings are expected to grow with 15.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.47%
EPS Next 3Y15.21%

More info and screens

0

5. Dividend

5.1 Amount

ARBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARBE ROBOTICS LTD

NASDAQ:ARBE (10/14/2025, 8:00:00 PM)

After market: 2.61 -0.03 (-1.14%)

2.64

+0.28 (+11.86%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-25 2025-11-25/bmo
Inst Owners35.51%
Inst Owner Change0%
Ins Owners5.71%
Ins Owner ChangeN/A
Market Cap286.89M
Analysts80
Price Target1.91 (-27.65%)
Short Float %3.8%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.5%
Min EPS beat(2)15.03%
Max EPS beat(2)15.97%
EPS beat(4)3
Avg EPS beat(4)5.67%
Min EPS beat(4)-16.42%
Max EPS beat(4)15.97%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)4
Avg EPS beat(12)-7.26%
EPS beat(16)5
Avg EPS beat(16)-105.53%
Revenue beat(2)1
Avg Revenue beat(2)-2.9%
Min Revenue beat(2)-60.78%
Max Revenue beat(2)54.98%
Revenue beat(4)1
Avg Revenue beat(4)-38.69%
Min Revenue beat(4)-75.74%
Max Revenue beat(4)54.98%
Revenue beat(8)2
Avg Revenue beat(8)-38.26%
Revenue beat(12)2
Avg Revenue beat(12)-42.05%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-21.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 535.24
P/FCF N/A
P/OCF N/A
P/B 4.95
P/tB 4.95
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.28%
ROE -84.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-77.96%
ROA(5y)-128.86%
ROE(3y)-135.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85.44%
Cap/Sales 89.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 2.34
Altman-Z 1.67
F-Score4
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)114.23%
Cap/Depr(5y)128.33%
Cap/Sales(3y)41.35%
Cap/Sales(5y)41.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y33.31%
EPS Next 2Y19.47%
EPS Next 3Y15.21%
EPS Next 5Y17.62%
Revenue 1Y (TTM)-64.48%
Revenue growth 3Y-30.11%
Revenue growth 5YN/A
Sales Q2Q%-33.01%
Revenue Next Year106.7%
Revenue Next 2Y169.17%
Revenue Next 3Y190.21%
Revenue Next 5Y152.15%
EBIT growth 1Y17.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.65%
EBIT Next 3Y14.59%
EBIT Next 5Y18.97%
FCF growth 1Y8.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.03%
OCF growth 3YN/A
OCF growth 5YN/A